IIVNTP Chronic & Neurological Infections Strategies For Immune & Inflammatory Diseases 2022

IIVNTP Chronic & Neurological Infections Strategies For Immune & Inflammatory Diseases 2022

Regular price
$20.00
Sale price
$20.00
Regular price
Sold out
Unit price
per 

International IV Nutritional Therapy Chronic & Neurological Infections Strategies For Immune & Inflammatory Diseases 2022

Format: 2 videos + 1 pdf, size: 6.02 GB

Course Audience: osteopathic physician

Overview:

APRIL 1 – 2, 2022 | AUSTIN, TX

Learn the Most Effective and Current Application of Parenteral (IV) Micronutrients: Vitamins, Minerals, Amino Acids, Botanical Extracts, Hydrogen Peroxide, DMSO, MSM, Lipoic Acid and Phosphatidylcholine. We will also cover the use of high dose IV vitamin C, central line access and care, germanium, sodium bicarbonate, and IV protocols.

OUR 2-DAY ADVANCED SEMINAR IS DESIGNED FOR NATUROPATHIC DOCTORS, MEDICAL DOCTORS, OSTEOPATHIC DOCTORS, REGISTERED NURSES, MEDICAL STUDENTS, AND OTHER INTERESTED MEDICAL PROFESSIONALS WHO HAVE ALREADY BEEN TRAINED IN THE FUNDAMENTALS OF IV NUTRIENT THERAPIES.

 

 

DAY 1 SATURDAY

9:00-10:00 Pharmacy of selected parenteral pharmaceuticals: Vitamins and Minerals including methylation and detox pathway support nutrients

10:00 – 10:45 Amino Acids in chronic infection/neurological cases Q/A

10:45-11:00 Exhibitor Break

11:00-12:30 Lyme and Mold Keynote: Dr. Jill Crista Amino Acids in chronic infection/neurological cases Q/A

12:30-1:30 Lunch break

1:30- 2:30 DMSO, MSM, HCL

2:30- 3:30 ALA/LAMC

3:30 -3:45 Exhibitor Break

3:45-5:00 Phosphatidylcholine and Glutathione Q and A

DAY 2 SUNDAY

9:00-10:00 Artemisinin, Curcumin, Botanical, Germanium

10:00 -11:00 IV Vitamin C: High and Low dose strategies in infections and neurological conditions Q/A

11:00– 11:15 Exhibitor Break

11:15– 12:00 Hydrogen Peroxide

12:00- 1:00 Lunch break

1:00 – 2:00 Peptides and Hormones

2:00- 3:00 Medical Ozone

3:00 – 3:15 Exhibitor Break

3:15-4:00 Ultraviolet Blood/LASER

4:00-4:15 What to do with Sensitive Patients Q/A